fbpx

ITC’s Botox Ruling Could Have Public Interest ImplicationsBy: La’Cee Conleyon February 4, 2021 at 5:15 pm Publication: IPWatchdog.com | Patents & Patent Law

Korean company Daewoong and its U.S. counterpart Evolus recently found themselves in a dispute with U.S.-Irish company Allergan and its counterpart Medytox over misappropriation of both a bacterial strain and the manufacturing process to make cosmetic injection products from that strain. Daewoong re  Read More>>

Categories   Courts, Government, International, IP News, IPWatchdog Articles, Korea, Litigation, Patents, Technology & Innovation, allergan, Botox, Daewoong, Evolus, innovation, intellectual property, International Trade Commission, patent, Section 337

YouTube
LinkedIn
LinkedIn
Share